DGI:Opportunistische Infektionen/Zerebrale Toxoplasmose/Quellen: Difference between revisions

From Infektiopedia
imported>Bestem
imported>Bestem
Line 1: Line 1:
==Quellen==
==Quellen==


# <span style="color: black">https://www.rki.de/DE/Content/Infekt/EpidBull/Merkblaetter/Ratgeber_Toxoplasmose.html;jsessionid=6F4003131E144DDB68FB03F9762455B6.internet082</span>
#<span style="color: black">https://www.rki.de/DE/Content/Infekt/EpidBull/Merkblaetter/Ratgeber_Toxoplasmose.html;jsessionid=6F4003131E144DDB68FB03F9762455B6.internet082</span>
# <span class="tocnumber"><span style="color: black">Toxoplasmosis in Germany. Pleyer U, Gross U, Schlüter D, Wilking H, Seeber F. Dtsch Arztebl Int. 2019 Jun 21;116(25):435-444. doi: 10.3238/arztebl.2019.0435.</span></span>
#Pleyer U, Gross U, Schlüter D, Wilking H, Seeber F. Toxoplasmosis in Germany. Dtsch Arztebl Int. 2019;116(25):435-444. doi:10.3238/arztebl.2019.0435
# <span class="tocnumber"><span style="color: black">Deutsch-Österreichische Leitlinien zur Therapie und Prophylaxe opportunistischer Infektionen bei HIV-infizierten erwachsenen Patienten; AWMF-Register-Nr.: 055-006; Federführung: Deutsche AIDS-Gesellschaft (DAIG) unter Beteiligung der Österreichischen AIDS-Gesellschaft (ÖAIG); Version 2.0 vom 12.09.2014</span></span>
#Schmidt-Hieber M, Silling G, Schalk E, et al. CNS infections in patients with hematological disorders (including allogeneic stem-cell transplantation)-Guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Medical Oncology (DGHO). Ann Oncol. 2016;27(7):1207-1225. doi:10.1093/annonc/mdw155
# <span class="tocnumber">CNS infections in patients with hematological disorders (including allogeneic stem-cell transplantation)-Guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Medical Oncology (DGHO). Schmidt-Hieber M, Silling G, Schalk E, Heinz W, Panse J, Penack O, Christopeit M, Buchheidt D, Meyding-Lamadé U, Hähnel S, Wolf HH, Ruhnke M, Schwartz S, Maschmeyer G. Ann Oncol. 2016 Jul;27(7):1207-25. doi: 10.1093/annonc/mdw155.</span>
#Ullmann AJ, Schmidt-Hieber M, Bertz H, et al. Infectious diseases in allogeneic haematopoietic stem cell transplantation: prevention and prophylaxis strategy guidelines 2016. Ann Hematol. 2016;95(9):1435-1455. doi:10.1007/s00277-016-2711-1
# <span class="tocnumber">Infectious diseases in allogeneic haematopoietic stem cell transplantation: prevention and prophylaxis strategy guidelines 2016. Ullmann AJ, Schmidt-Hieber M, Bertz H, Heinz WJ, Kiehl M, Krüger W, Mousset S, Neuburger S, Neumann S, Penack O, Silling G, Vehreschild JJ, Einsele H, Maschmeyer G; Infectious Diseases Working Party of the German Society for Hematology and Medical Oncology (AGIHO/DGHO) and the DAG-KBT (German Working Group for Blood and Marrow Transplantation). Ann Hematol. 2016 Sep;95(9):1435-55. doi: 10.1007/s00277-016-2711-1.</span>
#LL OI 2014-2.pdf. Accessed November 7, 2021. <nowiki>https://daignet.de/site-content/hiv-leitlinien/leitlinien-1/LL%20OI%202014-2.pdf</nowiki> <br />

Revision as of 17:44, 7 November 2021

Quellen

  1. https://www.rki.de/DE/Content/Infekt/EpidBull/Merkblaetter/Ratgeber_Toxoplasmose.html;jsessionid=6F4003131E144DDB68FB03F9762455B6.internet082
  2. Pleyer U, Gross U, Schlüter D, Wilking H, Seeber F. Toxoplasmosis in Germany. Dtsch Arztebl Int. 2019;116(25):435-444. doi:10.3238/arztebl.2019.0435
  3. Schmidt-Hieber M, Silling G, Schalk E, et al. CNS infections in patients with hematological disorders (including allogeneic stem-cell transplantation)-Guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Medical Oncology (DGHO). Ann Oncol. 2016;27(7):1207-1225. doi:10.1093/annonc/mdw155
  4. Ullmann AJ, Schmidt-Hieber M, Bertz H, et al. Infectious diseases in allogeneic haematopoietic stem cell transplantation: prevention and prophylaxis strategy guidelines 2016. Ann Hematol. 2016;95(9):1435-1455. doi:10.1007/s00277-016-2711-1
  5. LL OI 2014-2.pdf. Accessed November 7, 2021. https://daignet.de/site-content/hiv-leitlinien/leitlinien-1/LL%20OI%202014-2.pdf